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ABSTRACT	
MEGAN	ELISE	MCLEOD:	The	County-Level	Impact	of	Telemedicine:	A	Difference-in-Differences	
Analysis	of	the	University	of	Mississippi	Medical	Center’s	Telemedicine	Initiatives	
(Under	the	direction	of	Dr.	Mark	Van	Boening)	
	
Mississippi	has	the	fewest	active	physicians	per	capita	of	any	state,	consistently	
struggles	with	high	rates	of	acute	and	chronic	illness,	and	over	half	of	its	residents	live	in	rural	
areas	lacking	specialty	medical	care.	In	an	effort	to	bridge	the	state’s	geographical	gap	in	access	
to	healthcare,	the	University	of	Mississippi	Medical	Center	(UMMC)	has	introduced	
telemedicine.	This	study	conducts	an	analysis	of	some	of	the	societal	benefits	of	UMMC’s	
telemedicine	initiatives	using	a	difference-in-differences	identification	strategy.	This	model	
attempts	to	obtain	the	county-level	causal	effects	of	implementing	telemedicine	by	evaluating	
the	resulting	changes	in	length	of	life,	quality	of	life,	and	other	relevant	health	outcomes.	
Though	this	study	does	not	find	any	statistically	significant	results,	many	of	the	estimates	of	
these	changes	do	indicate	movement	in	the	direction	of	improved	county	health.	This	is	
encouraging	given	that	telemedicine’s	widespread	use	is	relatively	recent	and	the	analysis	may	
be	suffering	from	a	low	incidence	rate.	Some	of	the	estimates	are	also	large	with	large	standard	
errors,	indicating	that	some	telemedicine	programs	may	have	a	great	impact	though	this	model	
is	not	able	to	accurately	estimate	that	impact.	These	results	provide	hope	that	as	the	use	of	
telemedicine	continues	to	expand	in	the	state	of	Mississippi	collection	of	related	data	will	
enable	further	and	more	accurate	analysis.	
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I. Introduction	
	
The	“Digital	Revolution”	has	affected	nearly	every	human	activity,	including	healthcare.	
One	of	the	first	notions	of	using	electronic	technology	to	assist	in	providing	medical	care	came	
about	in	the	1960s	when	Larry	Weed	suggested	using	electronic	means	to	keep	track	of	patient	
information	(Budniak,	2017).	This	innovation	would	come	to	be	known	as	the	Electronic	Medical	
Record	or	EMR.	Others	soon	began	exploring	applications	of	technology	in	healthcare.	Dr.	
Michael	DeBakey	was	the	first	to	make	use	of	video,	transmitting	real-time	footage	of	an	open-
heart	surgery	overseas	by	satellite	in	1965.	Medical	staff	at	a	hospital	in	Geneva,	Switzerland,	
were	able	to	view	the	aortic	valve	replacement	procedure	DeBakey	was	performing	in	Houston	
(U.S.	Department	of	Veterans	Affairs,	2005).	This	concept	of	treating	patients	remotely	by	
technological	means	became	known	as	telemedicine.	
It	is	important	to	distinguish	between	telehealth	and	telemedicine.	While	often	used	
interchangeably,	they	do	have	distinct	definitions.	Telemedicine	refers	to	the	purely	clinical	
actions	of	providing	“curative	medical	treatment	for	established	disease”	over	a	spatial	distance	
using	technological	means	(Darkins	and	Cary,	2005,).	Telehealth,	on	the	other	hand,	
encompasses	“education	for	health,	public	and	community	health,	health	systems	development	
and	epidemiology,”	and	any	other	means	of	promoting	health	via	technology.	In	other	words,	
telemedicine	is	the	clinical	subset	of	the	broader	entity	telehealth	(Darkins	and	Cary,	2005).	
This	thesis	focuses	on	the	use	of	telemedicine.	There	is	a	growing	body	of	research	on	
the	clinical	efficacy	and	cost	reduction	benefits	of	utilizing	telemedicine,	particularly	in	rural	
medicine.	This	study	aims	to	contribute	to	that	research	by	conducting	an	analysis	of	some	of	
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the	societal	benefits	of	the	University	of	Mississippi	Medical	Center’s	recent	telemedicine	
initiatives.	The	analysis	utilizes	a	difference-in-differences	regression	framework	on	county-level	
data	from	the	period	of	2010-2017.	
Section	II	explores	the	background	of	telehealth	and	telemedicine.	Section	III	details	the	
current	state	of	health	and	use	of	telemedicine	in	the	state	of	Mississippi.	Section	IV	explains	the	
data	and	research	methodology	used	in	this	study.	Section	V	presents	the	regression	analysis.	
Section	VI	discusses	the	implications	of	the	results.	
II. Background	
	
The	history	of	telehealth	and	telemedicine	is	detailed	below,	but	a	key	turning	point	came	
about	with	the	advent	of	the	smartphone.	Its	popularization	has	been	likened	to	the	
development	of	the	printing	press	as	its	effects	have	been	of	a	similar	magnitude	(Topol,	2015).	
Perhaps	the	greatest	effect	of	the	smartphone	in	the	healthcare	sector	has	been	what	Dr.	Eric	
Topol	(2015)	refers	to	as	the	“democratization	of	medicine.”	In	essence,	the	smartphone	has	
empowered	patients	to	be	more	active	participants	in	their	well-being,	to	seek	out	and	evaluate	
physicians,	and	to	improve	the	accessibility	and	usability	of	their	healthcare	information.	
Smartphone	users	now	have	the	capability	to	record	details	almost	anytime	and	anywhere	–	
everything	from	pictures	to	their	own	heart	rate	–	and	then	send	them	to	another	user,	save	
them	for	later,	or	conduct	their	own	analysis.	This	newfound	ability	has	catalyzed	the	adoption	
of	telemedicine.	Over	the	past	few	decades,	several	leaders	in	the	medical	and	political	sectors	
have	realized	the	potential	for	the	cross-pollination	of	technology	and	healthcare,	leading	to	the	
formation	of	the	American	Telemedicine	Association	in	1993	and	the	establishment	of	the	Office	
of	the	National	Coordinator	for	Health	Information	Technology	(ONC)	in	2004.	
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The	promise	of	telehealth	and	telemedicine	has	become	evident	in	recent	years	with	
the	emergence	of	numerous	independent	telehealth	companies	like	Teladoc	as	well	as	the	
exploration	of	telemedicine	initiatives	by	large	healthcare	organizations	and	academic	medical	
centers.	In	their	book	Telemedicine	and	Telehealth	-	Principles,	Policies,	Performance,	and	
Pitfalls,	Dr.	Adam	Darkins	and	Dr.	Margaret	Cary	pronounce,	“Telehealth	has	the	ability	to	
improve	the	quality	of	healthcare,	provide	equity	of	access	to	healthcare	services,	and	reduce	
the	cost	of	delivering	healthcare”	(2005).	This	is	certainly	proving	to	be	true.	Telemedicine	and	
telehealth	are	in	their	infancy,	though.	While	studies	on	the	cost	effectiveness	and	clinical	
efficacy	of	utilizing	telehealth	have	been	conducted,	further	exploration	is	necessary,	especially	
with	regard	to	the	socioeconomic	impact	of	expanding	access	to	care.	
In	order	to	more	fully	understand	the	current	state	of	telemedicine	and	place	this	study	
into	context,	the	following	subsections	detail	the	history	of	telehealth	and	telemedicine,	the	
types	of	telemedicine,	some	prominent	benefits	of	utilizing	telemedicine,	current	policies	
pertaining	to	telemedicine,	and	existing	obstacles	to	increased	adoption.	
a. History	of	Telehealth	and	Telemedicine	
	
							The	prefix	“tele”	in	telemedicine	and	telehealth	comes	from	the	Greek	word	meaning	
distant.	If	the	literal	definition	of	telehealth	–	providing	health	care	services	at	a	distance	–	is	
considered,	then	it	is	not	a	revolutionary	idea.	Primitive	communication	technologies	were	used	
to	support	public	health.	For	example,	villages	and	ships	infected	with	communicable	diseases	
warned	travelers	to	keep	away	with	devices	like	signs,	flags,	and	bells,	thus	controlling	the	
spread	of	infectious	disease	(Darkins	and	Cary,	2005).	
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								 The	first	major	milestone	in	what	is	defined	as	telemedicine—providing	clinical	care	at	a	
distance—came	about	with	the	invention	of	the	telephone	in	1876.	A	patient	could	now	call	his	
or	her	doctor	to	receive	remote	medical	advice	or	to	summon	help.	The	telephone	is	currently	
used	extensively	in	the	delivery	of	healthcare.	A	patient	can	schedule	an	appointment	by	phone,	
a	mother	can	call	a	nurse	hotline	for	advice	after-hours,	a	physician	might	contact	a	colleague	
for	a	second	opinion,	or	an	attending	clinician	who	has	already	left	the	hospital	could	be	
updated	on	the	status	of	a	patient.	All	these	common	occurrences	are	instances	of	telehealth	
provided	via	telephone.	
								 What	is	now	thought	of	as	telemedicine—using	advanced	technology	to	provide	clinical	
care—grew	as	technology	rapidly	progressed	and	became	more	readily	available	to	the	public.	
Modern	telemedicine	had	its	beginnings	in	the	late	1960s	and	early	1970s.	Routine	
teleconsultations	took	place	over	a	closed-circuit	television	system	that	linked	the	Nebraska	
Psychiatric	Institute	to	a	remote	state	mental	hospital	during	this	time,	Dr.	Michael	DeBakey’s	
experimental	telesurgery	described	above	in	Section	I	took	place	in	1965,	and	the	first	national	
conference/workshop	on	telemedicine	took	place	in	1973	in	Ann	Arbor,	Michigan	(Darkins	and	
Cary,	2005).	
Despite	these	early	successes,	most	initial	telemedicine	projects	folded	due	to	various	
combinations	of	the	high	costs	of	the	technology,	poor	quality	of	the	imagery,	lack	of	demand	
for	the	service,	and/or	the	inability	to	integrate	with	mainstream	provision	of	healthcare	
(Darkins	and	Cary,	2005).	NASA,	remote	research	stations,	offshore	oil	rigs,	and	the	military	
were	virtually	the	only	parties	that	continued	to	support	the	development	of	telemedicine	from	
the	late	1970s	to	the	mid-1990s.	Interest	in	using	telemedicine	to	provide	care	for	the	general	
public	resurfaced	in	Norway	in	the	early	1990s.	The	Norwegian	government-funded	healthcare	
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system	along	with	Norway’s	numerous	remote	regions	lacking	specialist	physicians	provided	a	
unique	opportunity	for	the	implementation	of	telemedicine	(Darkins	and	Cary,	2005).	Upon	
seeing	Norway’s	success,	the	United	States	regained	interest	in	telemedicine	for	more	than	just	
extreme	situations.	By	1995,	the	US	reported	the	highest	number	of	annual	teleconsultations	of	
any	country	(Darkins	and	Cary,	2005).	This	resurgence	of	use	in	the	United	States	was	primarily	
focused	on	prison	and	rural	telemedicine	and	was	mostly	funded	by	government	grants	(Darkins	
and	Cary,	2005).	Commercial	telemedicine	activity	first	began	to	take	hold	in	radiology	and	has	
progressed	into	dermatology,	psychiatry,	cardiology,	and	other	specialties	(Darkins	and	Cary,	
2005).	
b. Types	of	Telemedicine	
	
								 There	are	three	types	of	telemedicine:	1)	store-and-forward,	2)	real-time,	and	3)	remote	
monitoring	(Lyuboslavsky,	2015).	Store-and-forward	refers	to	the	secure	electronic	transmission	
of	medical	information,	such	as	digital	images,	documents,	and	pre-recorded	videos.	An	
example	is	a	patient	taking	a	picture	of	a	rash	and	forwarding	it	to	a	dermatologist	for	diagnosis.	
The	clinician	is	then	able	to	review	the	transmission	and	send	back	a	diagnosis	and	treatment	
plan.	This	significantly	increases	efficiency,	but	might	not	provide	the	same	“healing	touch”	as	
in-person	or	real-time	consultations.	Real-time	telemedicine	occurs	when	a	patient	and	provider	
are	in	separate	physical	locations,	but	communicating	via	telephone,	video,	or	radio	with	one	
another	in	real	time.	This	is	a	close	proxy	to	a	traditional	face-to-face	visit,	but	does	not	provide	
as	many	efficiency	benefits	as	store-and-forward.	Remote	monitoring	involves	the	use	of	
sensors	to	track	patients’	body	function	and	behavior.	One	example	is	a	cardiologist	stationed	in	
another	location	in	the	hospital	keeping	tabs	on	his	or	her	patient’s	heartrate	in	the	ICU.	
Another	example	is	an	endocrinologist	analyzing	data	from	a	patient’s	internet-connected	
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blood-glucose	monitoring	device.	Remote	monitoring	faces	the	most	challenges	with	
reimbursement,	but	is	increasingly	coming	into	use	with	the	popularity	of	wearable	devices	and	
the	Internet	of	Things	(Lyuboslavsky,	2015).	
c. Benefits	of	Utilizing	Telemedicine	
	
The	benefits	of	telemedicine	include	improved	convenience	of	and	expanded	access	to	care,	
cost	reduction,	and	improved	outcomes.	
Improved	Convenience	of	and	Expanded	Access	to	Medical	Care	
	
	 Modern	technology	has	enhanced	interpersonal	connectedness	and	increased	access	to	
information.	A	colleague	who	lives	across	the	world	is	now	just	an	email	or	phone	call	away	and	
everything	from	definitions	to	directions	is	now	readily	retrieved	by	a	quick	internet	search.		It	is	
only	logical	that	such	convenience	would	extend	to	the	healthcare	field.		
There	are	at	least	three	improved	conveniences	from	telemedicine.	First,	telehealth	gives	
patients	expanded	access	to	information.	This	might	be	informative	webpages	about	specific	
diseases	and/or	treatments	on	the	Mayo	Clinic’s	website	or	a	platform	like	Epic	System’s	for	
accessing	one’s	personal	health	record.	Second,	telehealth	increases	patients’	connectedness.	
Examples	include	online	support	communities	such	as	PatientsLikeMe	(Topol,	2015).	Third,	
telemedicine	reduces	time	cost.	The	average	wait	time	for	an	appointment	with	a	primary	care	
physician	in	the	United	States	is	2.5	weeks	(Topol,	2015).	Patients	who	elect	to	have	a	store-and-
forward	teleconsultation	instead	of	an	in-person	consultation	need	not	schedule	an	
appointment,	drive	to	their	physician’s	office,	or	wait	to	be	seen.	Even	a	real-time	
teleconsultation	that	does	require	the	alignment	of	schedules	eliminates	the	need	for	travel.	
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Additionally,	new	telemedicine	groups	are	cropping	up	with	24/7	operating	hours	and	initiation	
to	treatment	plan	timeframes	of	24	hours	or	less	(Topol,	2015).	
Physicians	realize	an	increase	in	efficiency	with	these	tools,	too.	With	store-and-forward,	
clinicians	are	able	to	set	aside	a	block	of	time	to	review	multiple	stored	patient	transmissions	
without	interruption.	While	one	in-person	consultation	with	a	physician	can	last	from	10-30	
minutes,	“reviewing	a	store-and-forward	visit	takes	as	little	as	two	minutes”	(Lyuboslavsky,	
2015).	Based	on	these	numbers,	a	physician	could	complete	15	virtual	visits	in	the	time	it	might	
take	to	complete	one	in-person	consultation.	
Telemedicine	also	provides	the	benefit	of	greater	access	to	care.	“In	most	of	the	one-quarter	
of	the	United	States	that	is	considered	rural,	there	is	less	than	one	doctor	per	thirty-five	
hundred	people”	(Topol,	2015).	In	these	rural	communities,	individuals	requiring	care	might	be	
subject	to	even	longer	wait	times	for	an	appointment	with	that	one	local	doctor.	If	they	need	a	
specialist,	they	will	likely	have	to	travel	significant	distances	to	a	regional	hospital	or	academic	
medical	center,	a	luxury	in	time	and	expense	that	some	might	not	be	able	to	afford.	
Telemedicine	can	connect	people	in	rural	communities	to	a	local	hospital	or	to	a	specialist	across	
the	world	and	simultaneously	eliminate	the	need	to	travel.	Whether	a	personal	smartphone	or	a	
computer	at	their	local	clinic	is	the	means,	this	“flattening	of	the	world”	with	technology	can	
reduce	the	geographical	gap	related	to	healthcare	access.		
Cost	Reduction	
	
Telemedicine	can	also	reduce	cost.	In	some	cases,	such	cost	reduction	can	also	improve	
access.	Health	Partners,	an	insurer	based	in	Minnesota,	conducted	a	study	that	showed	an	$88	
average	cost	reduction	per	visit	when	using	virtual	visits	in	place	of	in-person	visits	(Anderson,	
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2013).	Those	without	insurance	can	benefit,	too.	A	basic	visit	with	a	physician	through	Teladoc	
costs	only	$38,	no	insurance	required	(though	many	telemedicine	sites	do	accept	insurance).	
Similarly,	Dermatologist	on	Call	only	charges	$59	for	a	dermatologist	review	of	a	rash.	These	
examples	contrast	with	an	average	cost	of	$160	for	an	uninsured	patient’s	in-person	visit	with	a	
primary	care	physician	(Saloner	et	al.,	2015).	Telehealth	also	garners	cost	savings	in	the	
management	of	chronic	conditions.	In	the	Liu	et	al.	(2016)	study	on	heart	failure	telehealth	
programs,	savings	ranging	from	$2,832	to	$5,499	(dependent	upon	the	severity	of	the	case)	
were	realized	per	patient	over	a	one-year	period.	
Improved	Clinical	Outcomes	
	
Improved	convenience,	expanded	access,	and	cost	reduction	would	mean	nothing,	though,	
if	the	standard	of	care	was	comprised.	Numerous	studies	have	shown	that	patients	prefer	virtual	
visits	and	that	their	clinical	efficacy	is	on	par	with,	if	not	better	than,	typical	in-person	visits	
(Topol,	2015).	For	example,	Topol’s	2015	study	of	teleconsultation	with	genetic	counselors	
demonstrated	that	these	teleconsultations	were	just	as	effective	as	in-person	consultations.	The	
Bashshur	et	al.	(2015)	study	on	telemedicine	intervention	in	diabetes	management	pointed	to	
positive	effects	of	telemonitoring	and	telescreening	in	terms	of	glycemic	control,	reduced	body	
weight,	and	increased	physical	exercise.	They	found	strong	and	consistent	evidence	of	improved	
glycemic	control	among	persons	with	Type	2	and	gestational	diabetes	along	with	effective	
screening	and	monitoring	of	diabetic	retinopathy.	
d. Policies	Pertaining	to	Telemedicine	
	
								 The	Health	Information	Technology	for	Economic	and	Clinical	Health	(HITECH)	incentive	
program	was	created	in	2008	to	address	the	sluggish	adoption	of	digital	technologies	by	the	
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healthcare	industry.	This	program	was	funded	by	$30	billion	out	of	the	$700	billion	stimulus	
package	initiated	by	the	Obama	administration	to	combat	the	2008	recession.	A	significant	
portion	of	this	$30	billion	went	to	promoting	the	adoption	of	electronic	health	records	(EHRs),	a	
component	of	telehealth	(Wachter,	2015).	The	Office	of	the	National	Coordinator	for	Health	
Information	Technology	(ONC),	created	in	2004,	was	tasked	with	overseeing	the	program	and	
was	successful	in	increasing	the	use	of	EHRs	in	clinical	hospitals	from	10%	to	about	70%	by	2014	
(Wachter,	2015).	
								 The	ONC	instituted	the	Meaningful	Use	policy	to	ensure	that	providers	receiving	the	
incentives	were	actually	utilizing	the	subsidized	technology.	Stage	1	of	the	policy	was	instituted	
in	2011	and	was	generally	thought	to	be	reasonable	and	helpful.	It	included	clauses	like	
“providing	clinical	summaries	to	patients	within	three	days	of	hospitalization	and	transmitting	a	
decent	proportion	of	prescriptions	electronically”	(Wachter,	2015).	Stage	2	was	rolled	out	in	
2014	and	evoked	disdain	in	the	healthcare	community.	It	required	hospitals	and	clinics	to	meet	
17	aggressive	core	objectives,	many	of	which	were	not	entirely	feasible	or	practical	in	the	
existing	healthcare	ecosystem.	One	of	the	requirements,	for	example,	was	that	more	than	5%	of	
patients	“view,	download,	and	transmit”	their	electronic	medical	information	to	a	“third	party,”	
like	a	subspecialist	using	a	different	EHR	(Wachter,	2015).	While	written	with	good	intent,	this	
requirement	was	not	practical.	Patient	portals	and	EHRs	had	to	be	reengineered	to	make	that	
act	possible	and	physicians	were	now	responsible	for	ensuring	their	patients	did	something	with	
their	newly	accessible	information.	Great	in	theory;	difficult	to	enact	when	the	demand	and	
culture	are	not	quite	present.	Meaningful	Use	Stage	1	did	encourage	the	implementation	of	
practical	technology	in	the	clinical	space,	but	Meaningful	Use	Stage	2	has	done	more	to	stifle	
innovation	with	its	impractical	stipulations	than	it	has	to	improve	health	information	technology	
(Wachter,	2015).	Common	critiques	of	ONC	policies	like	those	discussed	above	include	the	lack	
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of	focus	on	the	interoperability	between	EHRs	and	the	usability	of	health	information	
technology	(Wachter,	2015).	Looking	forward,	instituting	policies	to	encourage	different	EHRs	to	
interact	seamlessly	and	incentivizing	improved	usability	of	health	information	technology	for	the	
provider	and	patient	might	prove	useful.	
								 The	1996	Health	Insurance	Portability	and	Accountability	Act	(HIPAA)	is	another	policy	
that	has	impacted	the	field	of	telehealth.	This	law	was	enacted	in	part	to	protect	patient	privacy.		
Before	HIPAA,	there	were	no	generally	accepted	security	measures	or	true	requirements	for	
protecting	confidential	patient	information	in	the	healthcare	industry.	However,	the	need	for	
such	standards	became	apparent	as	the	industry	began	to	implement	information	technology	
systems	for	a	variety	of	functions,	both	clinical	and	administrative,	that	had	previously	been	
documented	on	paper.	While	this	switch	increased	efficiency,	it	also	created	new	potential	
security	risks	(U.S.	Department	of	Health	and	Human	Services,	2013).	HIPAA’s	Privacy	and	
Security	Rules	delineate	what	constitutes	protected	health	information	(PHI)	and	outline	the	
standards	for	securing	such	information.	In	January	2013,	a	modification	to	the	original	HIPAA	
called	the	“Final	Rule”	was	released	by	the	U.S.	Department	of	Health	and	Human	Services.	It	
expanded	the	requirement	of	HIPAA	compliance	to	include	any	entity	that	“creates,	receives,	
maintains	or	transmits	PHI”	where	it	had	initially	only	applied	to	“covered	entities”	such	as	
health	care	providers,	health	care	clearinghouses,	and	health	plans	and	it	also	increased	
penalties	for	violations	(U.S.	Department	of	Health	and	Human	Services,	2013).	These	updates	
are	particularly	troublesome	“…for	mobile	health	companies	in	a	rapidly	expanding	health	
information	technology	(HIT)	industry.	Although	there	is	much	interest	in	potential	partnerships	
between	innovative	companies	and	health	care	organizations	to	leverage	new	mobile	
technologies	(e.g.,	smartphones,	tablets,	mobile	monitors),	the	final	rule	may	impose	an	
unfunded	mandate	for	organizations,	which	ironically	may	impede	adoption	of	innovation	in	
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mobile	health”	(Wang	and	Huang,	2013).	While	evidently	necessary	and	well-intentioned,	
HIPAA’s	stringent	requirements	surrounding	the	use,	storage,	and	sharing	of	PHI	may	be	holding	
back	innovation.	Hospitals	and	clinics	must	focus	their	energies	on	preventing	a	HIPAA	violation	
at	all	costs,	and	small	healthcare	companies	may	be	less	able	to	compete	with	larger,	
established	firms	that	have	more	resources	to	bear	the	burden	of	these	additional	regulations.	
These	and	other	critiques	of	HIPAA	have	prompted	some	to	argue	that	the	“Department	of	
Health	and	Human	Services	may	need	to	reevaluate	and	adapt	its	regulations	to	keep	up	with	
the	advent	of	new	mobile	technologies	and	take	a	more	progressive	and	innovation-friendly	
approach	to	privacy	and	security”	(Wang	and	Huang,	2013).		
e. Obstacles	to	Adoption	
	
								 If	the	case	for	adopting	telemedicine	is	so	compelling,	then	why	is	it	not	ubiquitous?	
There	are	at	least	three	major	reasons:	1)	physician	reluctance,	2)	licensing	issues,	and	3)	
insurance	reimbursement.	
Physician	reluctance	is	a	notable	barrier.	Healthcare	is	somewhat	notorious	for	being	
slow	to	change,	e.g.,	even	the	stethoscope	was	balked	at	when	it	was	first	introduced.	Topol	
(2015)	attributes	much	of	this	attitude	to	the	paternalistic	culture	that	exists	in	medicine,	noting	
that	“the	doctor	knows	best”	is	more	than	just	a	colloquial	saying.	Hippocrates	himself,	the	
founding	father	of	medicine,	was	not	exactly	an	advocate	for	informed	consent:	he	wrote	and	
taught	that	a	physician	ought	to	decide	what	information	the	patient	could	handle	being	told.	
This	sort	of	medicine,	of	course,	is	not	taught	(and	hopefully	practiced)	anymore.	However,	the	
culture	has	been	passed	down,	thus	creating	the	sentiment	among	many	clinicians	that	
additional	technology	tends	to	frustrate	rather	than	augment	their	practice.	Physicians	are	also	
very	busy	individuals.	Experimenting	with	or	updating	constantly-evolving	tools	and	technology	
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may	not	be	a	top	priority	to	a	doctor	whose	system	already	works,	even	if	the	doctor	is	
technologically-savvy.	Implementing	telemedicine	can	therefore	appear	to	involve	substantial	
frustration	and	significant	time	loss.		
Current	licensing	regulations	also	stand	as	an	obstacle	to	the	proliferation	of	
telemedicine.	Despite	all	clinicians	being	board	certified	on	a	national	level	(every	physician	
takes	the	same	national	certification	exam),	they	are	licensed	at	the	state	level.	A	dermatologist	
licensed	to	practice	in	California	–	though	he	or	she	has	the	same	board	certification	as	a	
dermatologist	anywhere	else	in	the	country	–	could	not	provide	teleconsultation	services	to	a	
patient	in	Mississippi.	The	Interstate	Medical	Licensure	Compact	(IMLC)	has	been	created	in	an	
effort	combat	this	problem.	“The	IMLC	is	an	agreement	between	22	states	and	the	29	Medical	
and	Osteopathic	Boards	in	those	states.	Under	this	agreement	licensed	physicians	can	qualify	to	
practice	medicine	across	state	lines	within	the	Compact	if	they	meet	the	agreed	upon	eligibility	
requirements”	(Interstate	Medical	Licensure	Compact,	2018).	However,	if	a	national	licensing	
framework	was	established,	or	even	if	all	the	states	agreed	to	honor	each	other’s	medical	
licenses	as	they	do	with	drivers’	licenses,	this	obstacle	could	effectively	be	eliminated.	
The	ambiguity	surrounding	insurance	reimbursement	for	telehealth	services	is	another	
hindrance.	“In	a	poll	of	1,500	family	physicians,	only	15%	had	used	it	(telehealth)	in	their	
practices—but	90%	said	they	would	if	it	were	appropriately	reimbursed”	(Beck,	2016).	Insurance	
companies	have	been	grappling	with	how	to	reimburse	for	teleconsultations	practically	since	
telemedicine’s	inception.	Thankfully,	many	have	begun	to	reimburse	for	real-time	virtual	visits	if	
they	would	reimburse	for	the	same	service	in-person	(Beck,	2016).	Medicare	lags	behind,	
though.	“The	federal	health	plan	for	the	elderly	covers	a	small	number	of	telemedicine	
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services—only	for	beneficiaries	in	rural	areas	and	only	when	the	services	are	received	in	a	
hospital,	doctor’s	office	or	clinic”	(Beck,	2016).	
The	reimbursement	situation	is	particularly	problematic	when	it	comes	to	store-and-
forward,	remote	monitoring,	and	physician-physician	consults.	There	is	currently	no	nationally-
accepted	framework	for	insurance	reimbursement	for	these	types	of	services	(“State	Telehealth	
Laws	and	Reimbursement	Policies	Report,”	2017).	As	reimbursement	moves	from	a	fee-for-
service	schedule	to	an	outcomes-based	one,	these	issues	may	be	less	prevalent.	In	a	fee-for-
service	model,	a	hospital	charges	an	insurer	a	fee	for	each	test	and	procedure	performed.	
Whereas,	in	an	outcomes-based	model,	an	insurer	pays	a	pre-determined	fee	(according	to	a	
patient’s	diagnosis)	to	a	hospital	to	provide	care	for	a	patient.	The	hospital	keeps	any	savings	or	
is	responsible	for	any	additional	costs	above	the	actual	cost	to	treat	that	patient.	This	model	is	
meant	to	incentivize	efficient	and	quality	care.	Telemedicine	may	take	hold	more	quickly	in	this	
outcomes-based	model	because	providing	a	teleconsultation	or	tele-second-opinion	is	less	
costly	than	an	in-person	consultation	and	provides	a	comparable	outcome,	allowing	a	hospital	
to	profit	more	from	the	set	fee	(Beck,	2016).	
								 	Despite	these	obstacles,	there	is	much	to	be	explored	when	it	comes	to	the	impact	of	
and	use	of	technology	in	healthcare.	In	particular,	a	review	of	the	socioeconomic	impact	of	
telehealth	found	significant	benefit	in	areas	like	enhanced	access	to	and	quality	of	care,	but	
cited	the	limited	generalizability	of	studies	due	to	inconsistent	use	of	socioeconomic	indicators	
(Jennett	et	al.,	2003).	A	limited	number	of	specific	studies	on	management	of	chronic	conditions	
have	been	conducted,	but	there	is	certainly	need	for	more	in	order	to	develop	a	generalizable	
framework	for	widespread	implementation	of	effective	programs.	
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III. Mississippi	
	
Demographics,	policies,	and	telemedicine	programs	can	vary	widely	by	state.	As	this	study	
focuses	specifically	on	telemedicine	programs	instituted	in	the	state	of	Mississippi,	it	is	useful	to	
explore	the	current	demographics,	policies,	and	telemedicine	initiatives	therein.		
a. Current	Demographics	and	Health	in	Mississippi	
	
Pertinent	demographic	and	health	information	provided	by	Rural	Health	Information	
Hub	(2017)	about	Mississippi	includes:	
• Mississippi	has	an	estimated	population	of	2,988,726	people.		
• Nearly	54%	of	these	residents	live	in	what	is	considered	a	rural	area.	
• The	U.S.	Census	Bureau	reports	that	59.3%	of	the	state’s	population	is	white,	
37.7%	is	Black/African-American,	and	3.1%	is	of	Hispanic/Latino	origin.		
• Of	the	95	hospitals	in	the	state,	31	are	identified	as	Critical	Access	Hospitals.		
• Mississippi	has	177	Rural	Health	Clinics	and	21	Federally	Qualified	Health	
Centers	that	provide	services	at	188	sites	in	the	state.		
• There	is	only	one	academic	medical	center	and	one	children’s	hospital.		
• 12%	of	Mississippi	residents	lack	health	insurance.		
• The	average	per-capita	income	for	Mississippi	residents	in	2015	was	$34,771	
although	rural	per-capita	income	lagged	at	$32,432.		
• The	poverty	rate	in	rural	Mississippi	is	24.3%,	compared	with	16.8%	in	urban	
areas	of	the	state.		
• 20.8%	of	the	rural	population	has	not	completed	high	school,	while	13.8%	of	the	
urban	population	lacks	a	high	school	diploma.	
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• The	unemployment	rate	in	rural	Mississippi	is	6.4%,	while	in	urban	Mississippi,	it	
is	5.2%.		
When	it	comes	to	health	and	access	to	care,	Mississippi	has	long	lagged	behind	the	
national	average.	According	to	America’s	Health	Rankings,	the	state’s	core	measures	of	health	
have	collectively	placed	it	in	the	bottom	three	states	in	the	nation	for	overall	health	since	1990	
(“2017	Annual	Report	–	Mississippi”).	In	other	words,	Mississippi	has	not	been	ranked	higher	
than	47th	for	overall	core	measures	of	health	for	more	than	25	years.	In	2015,	Mississippi	had	
the	highest	rates	of	preterm	birth,	low	birthweight,	and	death	from	cardiovascular	disease,	
stroke,	diabetes,	and	septicemia	in	the	nation	(“Stats	of	the	State	of	Mississippi,”	2017).	It	also	
had	one	of	the	highest	rates	of	obesity	and	led	the	nation	in	physical	inactivity	(“2017	Annual	
Report	–	Mississippi”).	Sadly,	Mississippi	also	has	the	fewest	active	physicians	and	active	primary	
care	physicians	per	capita	of	any	state	(“Mississippi	Physician	Workforce	Profile”,	2017).	Though	
the	state	does	not	possess	substantial	disparities	in	health	status	by	education	level,	the	
geographic	disparities	are	notable	(“2017	Annual	Report	–	Mississippi”).	In	2017,	the	counties	in	
the	northwestern	part	of	the	state	that	comprise	the	Mississippi	Delta	(De	Soto,	Tate,	Tunica,	
Panola,	Coahoma,	Quitman,	Tallahatchie,	Bolivar,	Leflore,	Grenada,	Sunflower,	Carroll,	Holmes,	
Humphreys,	Washington,	Sharkey,	Issaquena,	Yazoo,	and	Warren)	all	ranked	in	the	bottom	
quartile	of	health	factors	for	the	state.	These	health	factors	include	health	behaviors,	quality	
and	availability	of	clinical	care,	social	and	economic	factors,	and	physical	environment	
(“Mississippi	Health	Factors	Rankings”).		
Given	the	state’s	struggles	with	debilitating	chronic	diseases,	shortage	of	healthcare	
providers,	and	significantly	rural	population,	Mississippi	seems	an	excellent	candidate	for	
implementing	telemedicine	in	an	attempt	to	increase	access	to	care	and	efficiency.	
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b. Telemedicine	in	Mississippi	
	
According	to	the	American	Telemedicine	Association,	Mississippi	receives	an	overall	
grade	of	“A”	for	their	policies	on	coverage	and	reimbursement	of	telemedicine	based	on	health	
plan	parity	and	Medicaid	conditions	of	payment.	Only	nine	states	in	the	nation	received	that	
designation	in	2017.	Of	the	thirteen	indicators	analyzed,	Mississippi	had	“A’s”	for	ten.	For	
“eligible	technologies”	and	“informed	consent”	under	Medicaid	Service	Coverage	and	
Conditions	of	Payment,	Mississippi	received	“B’s”—due	to	stringent	rules	for	eligible	
technologies	and	requirement	of	an	“unspecified	method	of	obtaining	consent”—and	did	not	
receive	a	grade	for	rehabilitation	services	as	they	are	not	currently	offered	in	the	state.	
Mississippi	was	also	lauded	by	the	report	for	its	innovative	payment/service	delivery	models	for	
correctional	facilities	(“State	Telemedicine	Gaps	Analysis,”	2017).		
	 Why	is	Mississippi	considered	one	of	the	top	states	for	telemedicine	policy?	In	2013,	
Mississippi	enacted	a	parity	law	that	required	private	insurers,	state	employee	health	plans,	and	
public	assistance	to	consider	services	provided	via	telemedicine	equivalent	to	services	they	
cover	when	provided	through	in-person	consultation.	The	code	further	requires	that	
deductibles,	co-payments,	and	coinsurance	must	not	be	greater	for	the	provision	of	a	specific	
service	via	telemedicine	than	that	same	service	provided	via	in-person	consultation	(Miss.	Code	
Ann.,	2013).	This	true	parity	in	status	and	payment	is	rare	even	among	states	who	have	enacted	
parity	laws.	
Additionally,	though	the	code	initially	stipulated	that	the	telemedicine	consultation	had	
to	be	in	real-time	(i.e.,	not	audio-only,	telephone,	email,	or	facsimile),	the	code	was	amended	in	
2014	to	include	parity	in	reimbursement	for	store-and-forward	and	remote	patient	monitoring	
	 17	
services	(Miss.	Code	Ann.,	2014).	This	section	of	the	code	also	outlines	the	appropriate	value	of	
reimbursement	of	remote	patient	monitoring	as	it	can	be	difficult	to	compare	this	type	of	
service	to	an	in-person	consultation.	
Mississippi	also	has	no	geographic	restrictions	on	where	service	can	be	provided—other	
than	that	the	patient	must	reside	within	the	state—and	honors	a	wide	range	of	specialties,	even	
going	so	far	as	to	allow	a	non-Mississippi-based	provider	(who	is	licensed	to	practice	in	
Mississippi)	to	be	reimbursed	for	store-and-forward	services	not	available	in	Mississippi	(Miss.	
Code	Ann.,	2014).	The	University	of	Mississippi	Medical	Center’s	(UMMC’s)	Center	for	
Telehealth	has	worked	and	continues	to	work	closely	with	state	and	national	legislators	to	
advocate	for	telehealth	and	develop	sound	policies	to	facilitate	its	adoption.		
	 One	obstacle	to	the	provision	of	telehealth	in	rural	areas	is	the	lack	of	accessibility	to	
high	speed	internet	connection.	Per	2016	data	compiled	by	the	Federal	Communications	
Commission,	“79	percent	of	Mississippi	households	are	not	connected	to	internet	at	speeds	
defined	as	broadband	—	25	megabits	per	second	downstream	and	three	megabits	per	second	
upstream”	(Wolfe,	2017).	UMMC	works	with	the	rural	clinics	where	it	provides	telemedicine	
services	to	ensure	they	have	high-speed	internet	capabilities.	For	remote	patient	monitoring	
programs,	patients	are	provided	a	tablet	with	a	data	plan	and	their	cell	service	is	checked	to	
ensure	their	connection	will	be	supported	(Wolfe,	2017).	
	 Overall,	Mississippi	is	a	national	leader	in	telemedicine,	thanks	in	large	part	to	UMMC’s	
Center	for	Telehealth.	There	remains	potential	for	growth	in	several	areas,	which	should	be	
bolstered	by	UMMC’s	recent	recognition	as	a	National	Telehealth	Center	of	Excellence	and	the	
associated	grant	to	support	research	and	development	(University	of	Mississippi	Medical	Center,	
2017).	
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c. Telemedicine	at	the	University	of	Mississippi	Medical	Center	
	
	 In	Mississippi,	residents	in	53	of	the	state’s	82	counties	are	more	than	a	40-minute	drive	
from	specialty	care	(Michael	Adcock,	FACHE,	e-mail	correspondence,	May	2017).	This	causes	a	
troublesome	delay	in	the	receipt	of	necessary	care	and	increases	health	risks,	especially	for	
emergency	situations	that	require	quick	intervention.	The	resulting	burden	on	local	hospitals	is	
also	problematic	due	to	the	number	of	patients	that	have	to	be	transferred	to	a	higher	level	of	
care.	Local	hospitals	consequently	lose	desperately	needed	reimbursement	to	larger	medical	
centers	which	possess	the	specialty	care	that	local	hospitals	lack.		
The	University	of	Mississippi	Medical	Center	(UMMC)—the	only	academic	medical	
center	in	the	state—recognized	this	geographical	disparity	in	access	to	care	and	sought	to	
“shrink	the	gap”	by	utilizing	technology.	In	2003,	UMMC	began	offering	specialty	emergency	
care	via	live	tele-consults	with	rural	hospitals	and	clinics.	In	2008,	UMMC	added	a	TelePsychiatry	
program.	In	2011,	a	full-time	staff	was	dedicated	to	telehealth.	Then,	in	2013,	the	UMMC	Center	
for	Telehealth	was	officially	formed	with	a	24/7	Telehealth	Call	Center.	“More	than	500,000	
patient	visits	in	69	of	the	state’s	82	counties	have	been	recorded	since	the	center	began	(in	
2003)	with	just	three	sites,	expanding	to	more	than	200	sites	today,	not	including	the	homes	of	
patients”	(University	of	Mississippi	Medical	Center,	2017).	In	2017,	the	Center	was	named	a	
national	Telehealth	Center	of	Excellence	by	the	Health	Resources	and	Services	Administration,	
an	agency	of	the	U.S.	Dept.	of	Health	and	Human	Services.	This	national	honor	comes	with	over	
$2	million	in	grant	funding	to	promote	research	on	telehealth	and	to	aid	the	center’s	support	of	
other	telehealth	programs	that	seek	their	assistance	(University	of	Mississippi	Medical	Center,	
2017).	The	Center	provides	remote	access	to	practitioners	in	more	than	35	specialties.	
Additionally,	telehealth	nurse	practitioners	work	as	part	of	a	multidisciplinary	team	that	includes	
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a	certified	emergency	medicine	physician	on	the	UMMC	campus	to	treat	patients	in	the	
emergency	departments	of	17	rural	Mississippi	hospitals.	The	Center	also	recently	debuted	its	
“UMMC	2	You”	program	offered	online	throughout	Mississippi	to	individuals	and	families	on	the	
state	employee	insurance	plan	and	through	select	schools	and	companies	for	the	treatment	of	
minor	medical	issues	(University	of	Mississippi	Medical	Center,	2017).	
IV. Data	
	
Data	related	to	health	outcomes,	health	factors,	and	demographics	were	obtained	from	
the	County	Health	Rankings	and	Roadmaps	website	(http://www.countyhealthrankings.org/	
rankings/data/	MS).	Specific	outcome	variables—such	as	deaths	related	to	the	circulatory	
system—were	sourced	from	the	CDC	Wonder	Online	Database	website	(https://wonder.cdc.	
gov).	This	database	compiles	information	on	the	number	of	deaths	and	causes	of	death	
according	to	the	International	Classification	of	Diseases,	Tenth	Revision	(ICD10)	codes.	These	
data	cover	all	82	counties	in	the	state	of	Mississippi	from	the	period	of	2010-2017.	Additionally,	
UMMC’s	Center	for	Telehealth	provided	information	regarding	the	start	date	of	each	service	line	
in	the	64	counties	where	they	had	contracts	and	were	operating	as	of	November	2017	(Megan	
Duet,	MS,	e-mail	communication,	November	2017).	
These	data	are	used	to	test	whether	the	implementation	of	telemedicine	programs	
(both	generally	and	two	specific	service	lines)	affected	health	outcomes	in	the	counties	they	
served.	The	general	effects	of	the	programs	are	evaluated	via	improvements	in	length	of	life	and	
quality	of	life	occurring	after	implementation	of	telemedicine	programs.	Length	of	life	is	
evaluated	in	terms	of	years	of	potential	life	lost	(YPLL)	which	is	defined	in	this	dataset	as	the	
age-adjusted	years	of	potential	life	lost	before	age	75	per	100,000	population.	The	CDC	explains	
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that	“YPLL	is	calculated	by	subtracting	the	age	at	death	from	the	standard	year,	and	then	
summing	the	individual	YPLL	across	each	cause	of	death.	For	example,	if	three	people	died	from	
a	certain	cause	who	were	ages	2,	37,	and	74,	the	YPLL-65	for	that	cause	of	death	would	be	(65-2)	
+	(65-37)	=	63	+	28	=	91.	Note	that	the	YPLL	calculation	does	not	include	people	who	died	at	the	
benchmark	age	or	older.	For	instance,	choosing	65	as	the	benchmark	age	excludes	people	who	
died	at	age	65	or	older	from	the	calculation	of	YPLL-65”	(“Definitions	for	Years	of	Potential	Life	
Lost,”	2014).	Quality	of	life	is	evaluated	in	terms	of	poor	physical	health	days	(PPHD)	per	person	
per	year.	In	this	dataset,	PPHD	are	defined	as	the	average	number	of	physically	unhealthy	days	
reported	in	the	past	30	days	(age-adjusted)	from	the	Behavioral	Risk	Factor	Surveillance	System	
(BRFSS).	The	BRFSS	is	a	system	of	telephone	surveys	that	collect	data	about	U.S.	residents’	
health-related	risk	behaviors,	chronic	health	conditions,	and	use	of	preventive	services.	These	
length	of	life	and	quality	of	life	outcome	variables	are	used	to	evaluate	the	effects	of	the	general	
presence	of	telemedicine	in	a	county	depending	on	whether	the	county	had	one	or	more	service	
lines	versus	no	service	lines.		
Additionally,	the	impact	of	two	specific	telemedicine	service	lines—tele-cardiology	and	
tele-primary	care	(with	a	nurse	practitioner)—are	investigated	based	on	one	or	more	specific	
health	outcome	variables	related	to	the	given	service	line.	The	impact	of	tele-cardiology	is	
evaluated	based	on	the	number	of	circulatory	system-related	deaths	(per	100,000	population;	
CSD).	The	impact	of	tele-primary	care	is	evaluated	based	on	two	outcome	measures:	the	
preventable	hospitalization	rate	(PHR)	and	the	percentage	of	diabetic	Medicare	enrollees	age	
65-75	that	receive	HbA1c	monitoring	(PctDM).	Preventable	hospitalizations	are	admissions	to	a	
hospital	for	certain	acute	illnesses	like	dehydration	or	for	worsening	chronic	conditions	that	
might	not	have	required	hospitalization	had	they	been	successfully	managed	in	outpatient	
settings.	In	this	dataset,	PHR	is	defined	as	the	number	of	hospital	stays	for	ambulatory-care	
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sensitive	conditions	per	1,000	Medicare	enrollees.	PctDM	measures	the	general	health	of	
elderly	diabetics.	HbA1c	tests	indicate	how	high	a	person’s	blood	sugar	has	been	on	average	for	
the	past	8-12	weeks.	Monitoring	HbA1c	is	thought	to	be	one	of	the	best	ways	to	see	if	a	person’s	
diabetes	is	well-managed.	Due	to	expected	non-normality	in	the	distribution	of	these	variables,	
the	log	of	each	outcome	variable	is	used	in	the	regressions.	
To	account	for	any	potentially	confounding	factors	from	different	demographic	and	
socioeconomic	compositions	of	counties,	control	variables	are	included	in	the	regressions.	The	
same	control	variables	are	used	in	all	regressions.	These	include	the	percentage	of	the	county	
that	is	younger	than	18,	percentage	of	the	county	that	is	older	than	65,	racial	make-up	of	the	
county,	percentage	considered	rural,	median	income,	percentage	unemployed,	percentage	with	
only	a	high	school	education,	percentage	of	children	in	poverty,	and	percentage	who	do	not	
speak	English.	These	variables	capture	differences	in	health	outcomes	attributable	to	age,	race,	
education,	and	socioeconomic	status.			
Table	1	provides	descriptive	statistics	on	the	outcome	variables	and	the	control	
variables.	Both	weighted	(by	county	population)	and	unweighted	means	for	each	of	the	
variables	are	reported.	Standard	deviations	are	given	in	parentheses.	As	shown	in	Table	1,	per	
100,000	people,	there	are	an	(weighted)	average	of	10,453.02	years	of	potential	life	lost	each	
year	per	county	for	the	period	of	2010-2017.	This	means	that,	on	average,	premature	deaths	
(before	age	75)	due	to	accident,	disease,	mismanagement	of	a	chronic	condition,	or	some	other	
cause	resulted	in	0.10	years	(or	1.25	months)	of	potential	life	lost	per	person	each	year.	
Likewise,	across	all	counties,	each	person	experienced	an	(weighted)	average	of	4.093	days	of	
poor	physical	health	each	month.		
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Table	1:	Descriptive	Statistics	 	  
Dependent	Variables	
Weighted	Mean	
(std.	err.)	
Unweighted	
Mean	(std.	err.)	
Years	of	Potential	Life	Lost	(YPLL)	 10453.02	 11245.87	
	 (262.4341)	 (203.9679)	
Poor	Physical	Health	Days	(PPHD)	 4.093	 4.3767	
	 (.0888)	 (.05797)	
Deaths	Related	to	Circulatory	System	(per	
100,000	Population;	CSD)	 229.6379	 122.5378	
	 (42.9707)	 (11.0635)	
Preventable	Hospitalization	Rate	(PHR)	 85.518	 96.0832	
	 (2.7748)	 (2.3884)	
Diabetic	Medicare	Enrollees	Age	65-75	
Receiving	hbA1c	Monitoring	(%*100;	PctDM)	 80.89511	 80.471	
	 (.71181)	 (.5499)	
Control	Variables	 	  
County	Population	 84277.28	 36303.92	
	 (16743.41)	 (4634.134)	
Percentage	Younger	Than	18	 25.0745	 24.7023	
	 (.2642)	 (.25986)	
Percentage	65	and	Older	 13.5786	 14.6436	
	 (.3059)	 (.2396)	
Percentage	African	American	 37.1237	 40.8185	
	 (3.4703)	 (2.2584)	
Percentage	American	Indian	or	Alaska	Native	 0.5662	 0.6411	
	 (.1685)	 (0.2106)	
Percentage	Asian	 0.9565	 0.5289	
	 (.1608)	 (0.0637)	
Percentage	Native	Hawaiian	or	Pacific	Islander	 0.0459	 0.0289	
	 (0.0081)	 (0.0055)	
Percentage	Hispanic	 2.8134	 2.3099	
	 (0.2741)	 (0.1845)	
Percentage	Female	 51.4571	 51.1584	
	 (0.1941)	 (0.2350)	
Percentage	Rural	 50.5332	 70.2359	
	 (4.4623)	 (2.8157)	
Median	Income	 39235.43	 34498.92	
	 (1687.292)	 (776.1693)	
High	School	Graduation	Rate	 71.9427	 71.3297	
	 (1.0042)	 (0.6691)	
Percentage	Unemployed	 8.8678	 10.1521	
	 (0.3152)	 (0.2596)	
Number	Children	in	Poverty	 32.78	 35.6189	
	 (0.9916)	 (0.7840)	
Percentage	Non-English	Speaking	 1.0902	 0.8563	
		 (0.1139)	 (0.0965)	
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V. Identification	Strategy	
	
In	order	to	distinguish	the	effects	of	telemedicine	on	health	outcomes	from	confounding	
causes	(more	public	funds	allocated	to	healthcare,	a	push	for	enrollment	in	Medicare,	etc.),	the	
variation	across	counties	resulting	from	the	rolling	implementation	of	UMMC	telemedicine	
programs	from	2010-2017	is	exploited	using	a	difference-in-differences	research	design.	The	
difference-in-differences	model	is	a	statistical	technique	used	to,	in	a	sense,	mimic	a	
randomized	experiment	using	available	observational	data.	The	model	elicits	the	causal	
outcome	of	a	treatment	by	comparing	the	outcome	changes	before	and	after	the	treatment	is	
administered	in	the	treatment	group	to	those	in	the	control	group.	The	control	group	does	not	
receive	the	treatment	at	any	point	and	data	are	observed	for	the	same	period	of	time	as	the	
treatment	group.	The	treatment	group	is	observed	prior	to	the	start	of	treatment	and	after	
treatment	has	been	administered.	Difference-in-differences	is	useful	in	observational	
experiments	where	delivery	of	the	treatment	cannot	be	completely	randomized.	In	order	for	the	
model	to	be	valid,	the	control	group	must	be	similar	in	trend	to	the	treatment	group	prior	to	the	
treatment	being	delivered.	This	design	removes	any	bias	that	may	have	existed	from	the	prior	
trend	in	an	estimate	that	simply	compares	the	outcomes	before	and	after	treatment.	If	the	
assumption	holds,	then	the	difference-in-differences	model	can	be	used	to	find	the	change	in	
outcome	that	directly	resulted	from	the	treatment.		
The	general	regression	format	used	is:	
				𝑦𝑖𝑡	=	𝛼	+	𝛽1𝑇𝑟𝑒𝑎𝑡𝑖	+	𝛽2𝑃𝑜𝑠𝑡𝑡	+	𝛽3𝑇𝑟𝑒𝑎𝑡𝑖×𝑃𝑜𝑠𝑡𝑡	+	𝛽4	X𝑖𝑡	+	𝑢𝑖𝑡		 																																								(1)	
Dependent	variable	𝑦𝑖𝑡	is	the	outcome	in	unit	i	in	time	period	t.		The	independent	variables	𝑇𝑟𝑒𝑎𝑡𝑖	and	𝑃𝑜𝑠𝑡𝑡	are	dummy	variables.	𝑇𝑟𝑒𝑎𝑡𝑖	=1	if	observation	𝑦𝑖𝑡	is	from	a	unit	in	the	
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treatment	group	and	=	0	if	it	is	from	a	unit	in	the	control	group,	and	𝑃𝑜𝑠𝑡𝑡	=	1	if	𝑦𝑖𝑡	is	observed	after	the	time	period	in	which	the	treatment	was	administered	and	=	0	if	𝑦𝑖𝑡	is	observed	prior	to	that	time.	Thus,	coefficient	𝛽1	captures	the	differences	between	treatment	
and	control	groups	that	do	not	vary	with	time	(e.g.,	differing	climate	types)	and	coefficient	𝛽2	
accounts	for	shocks	that	occur	simultaneously	for	both	treatment	and	control	groups	(e.g.,	a	
change	in	the	federal	tax	code).	The	variable	𝑇𝑟𝑒𝑎𝑡𝑖×𝑃𝑜𝑠𝑡𝑡	captures	the	interaction	between	𝑇𝑟𝑒𝑎𝑡𝑖	and	𝑃𝑜𝑠𝑡𝑡.	Notice	that	𝑇𝑟𝑒𝑎𝑡𝑖×𝑃𝑜𝑠𝑡𝑡	=	1	only	if	unit	i	is	in	the	control	group	and	period	t	
occurs	after	treatments	was	administered,	and	=	0	otherwise.		Therefore,	coefficient	𝛽3	is	the	
main	parameter	of	interest	because	it	represents	the	pre/post	difference	for	the	treatment	
group	minus	the	pre/post	difference	for	the	control	group.	In	simpler	terms,	𝛽3	is	the	estimated	
causal	effect	of	treatment	after	accounting	for	time-invariant	and	time-specific	differences.	
Variable	X𝑖𝑡	represents	the	vector	of	control	variables.	The	random	error	term	𝑢𝑖𝑡	represents	the	
difference	between	the	outcome	predicted	by	the	model	and	that	which	is	actually	observed.	
For	the	purposes	of	this	study,	the	format	of	the	regression	used	is	Model	1	(M1):	
Outcome𝑖t	=	𝛼	+	𝛽1HadTelemed𝑖t	+	Countyi	+	Yeart	+	𝛽2X𝑖𝑡	+	𝑢𝑖𝑡																																											(2)	
Outcome𝑖t	is	one	of	the	health	outcomes	for	county	i	in	year	t	(YPLL,	CSD,	PHD,	PHR,	or	PctDM;	
see	Table	1	above).	HadTelemed𝑖t	is	essentially	the	𝑇𝑟𝑒𝑎𝑡𝑖×𝑃𝑜𝑠𝑡𝑡	variable	from	the	general	
specification	shown	above	in	equation	(1):	it	=	1	in	any	year	t	when	county	i	has	an	active	
telemedicine	program	and	=	0	in	any	year	in	which	there	was	no	active	program.	Countyi	and	Yeart	are	county	and	fixed	effects,	respectively,	that	take	the	place	of	𝑇𝑟𝑒𝑎𝑡𝑖	and	𝑃𝑜𝑠𝑡𝑡	in	
equation	(1).	These	variables	do	not	have	coefficients	because	they	are	fixed	effects,	not	
random	variables.	The	fixed	effects	model	is	used	here	because	unobservable,	time-invariant	
effects	(e.g.,	culture)	are	tied	to	the	observable	independent	variables	(e.g.,	implementation	of	
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telemedicine).	X𝑖𝑡	again	represents	the	collection	of	control	variables	and	𝑢𝑖𝑡	is	the	error	term.	
Robust	standard	errors	clustered	at	the	county	level	are	used	to	avoid	overstating	the	
significance	of	estimates	due	to	serial	error	correlations	within	groups	(Bertrand,	Duflo,	and	
Mullainathan,	2004).		
In	this	case,	the	identifying	assumption	is	that	had	implementation	of	telemedicine	not	
occurred	anywhere,	the	treatment-group	counties	would	have	followed	a	similar	trend	in	health	
outcomes	to	control-group	counties	during	the	period	of	evaluation.	Below	in	Section	VI,	this	
assumption	is	tested	with	both	regressions	and	graphics.	The	format	of	the	regressions	used	to	
test	the	assumption	is	Model	2	(M2):	
Outcome𝑖t	=	𝛼	+	𝛽1HadTelemed𝑖t	+	𝛽2leadp𝑖t	+	Countyi	+	Yeart	+	𝛽3X𝑖𝑡	+	𝑢𝑖𝑡		 	(3)	
Equation	(3)	is	identical	to	equation	(2)	except	for	the	inclusion	of	variable	leadp𝑖t,	which	is	a	
leading	indicator	that	=	1	if	the	observation	of	Outcome𝑖t	occurs	within	p	periods	before	the	
implementation	of	a	telemedicine	program	(e.g.,	p	=	2	indicates	a	window	of	0	to	2	years)	for	a	
county	in	the	treatment	group	and	=	0	otherwise.	If	the	inclusion	of	this	indicator	yields	a	
statistically-significant	coefficient	(𝛽2),	then	the	identifying	assumption	may	not	be	valid.	
	 Graphically,	evidence	of	divergence	in	the	trends	of	treatment	and	control	counties	
prior	to	implementation	indicates	a	violation	of	the	identifying	assumption.	This	divergence	in	
trends	is	shown	visually	by	graphing	the	coefficient	estimates	for	leading	and	lagging	indicators	
specific	to	each	year	pre-	and	post-implementation.	The	regressions	used	to	obtain	these	
estimates	follow	the	formats	shown	in	equations	(4)	and	(5):	
Outcome𝑖t	=	𝛼	+	𝛽1HadTelemed𝑖t	+	𝛽4YrPrep𝑖t	+	Countyi	+	Yeart	+	𝛽3X𝑖𝑡	+	𝑢𝑖𝑡																	 (4)	
Outcome𝑖t	=	𝛼	+	𝛽1HadTelemed𝑖t	+	𝛽5YrPostp𝑖t	+	Countyi	+	Yeart	+	𝛽3X𝑖𝑡	+	𝑢𝑖𝑡																																			(5)	
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Here,	YrPrep𝑖t	=	1	when	observation	Outcome𝑖t	occurs	within	p	periods	before	implementation	
of	the	telemedicine	program	(e.g.,	if	p	=	1,	YrPre1𝑖t	=	1	when	Yeart	=	2013	and	if	the	telemedicine	
program	was	implemented	in	2014	for	that	county)	and	=	0	otherwise.	Likewise,	YrPostp𝑖t	=	1	
when	observation	Outcome𝑖t	occurs	within	p	periods	after	implementation	of	the	telemedicine	
program.	Graphing	these	𝛽4	and	𝛽5	coefficient	estimates	gives	a	visual	representation	of	the	
difference	in	trends	of	a	health	outcome	between	treatment	and	control	counties	over	time.	If	
the	identifying	assumption	holds,	𝛽4	estimates	from	equation	(4)	will	be	close	to	zero—meaning	
the	pre-implementation	trends	in	Outcome𝑖t	for	treatment	and	control	groups	do	not	differ.		
Additionally,	if	the	𝛽5	estimates	from	equation	(5)	trend	in	one	direction	or	the	other	after	
implementation,	this	would	indicate	that	implementation	had	an	effect	on	Outcome𝑖t	in	the	
treatment	group,	but	not	the	control	group.	The	𝛽5	estimates	capture	the	dynamic	effects	of	the	
treatment	whereas	𝛽1	represents	the	overall	average	effect.	These	dynamic	effects	can	be	
masked	when	only	considering	the	overall	effect,	so	visually	representing	the	dynamic	effects	
can	be	useful.	For	the	five	dependent	variables	considered	here,	lower	values	indicate	better	
health.		Thus,	negative	post-implementation	𝛽5	estimates	would	indicate	that	(on	average)	
telemedicine	improved	county	health.	
VI. Results	
a. Length	and	Quality	of	Life	
	
First,	an	examination	is	conducted	on	whether	implementing	any	telemedicine	program	has	
an	effect	on	length	of	life	or	quality	of	life	using	the	broad-measure	outcome	variables	YPLL	
(Years	of	Potential	Life	Lost)	and	PPHD	(Poor	Physical	Health	Days).	If	telemedicine	has	a	positive	
effect,	then	YPLL	and	PPHD	will	decline	after	implementation.	The	results	from	estimating	
equation	(2)	are	shown	in	Table	2.		For	the	variable	leadp𝑖t,	the	leading	period	is	p	=	2	years.		The		
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Table	2:	Impact	of	Telemedicine	on	Length	and	Quality	of	
Life	 	   
		
OLS	-	Weighted	by	
County	Pop.	 		 OLS	-	Unweighted	
	 M1	 M2	 	 M1	 M2	
Panel	A:	Length	of	Life	 Log(YPLL)	 		 Log(YPLL)	HadTelemed𝑖t	 -0.00351	 -0.0028	 	 0.0093	 0.0109	
	 (0.0136)	 (0.0137)	 	 (0.0159)	 (0.0162)	
	 p	=	0.797	 p	=	0.839	 	 p	=	0.560	 p	=	0.505	
0	to	2	Years	Before	
Implementation	of	Telemedicine	
	 0.0058	 	  0.0122	
	 (0.0125)	 	  (0.0207)	
	  p	=	0.642	 	  p	=	0.557	
	      
Observations	 649	 649	 	 649	 649	
Panel	B:	Quality	of	Life	 Log(PPHD)	 		 Log(PPHD)	HadTelemed𝑖t	 -0.0152	 -0.0183	 	 0.0324	 0.0283	
	 (0.0249)	 (0.0247)	 	 (0.0263)	 (0.0258)	
	 p	=	0.543	 p	=	0.460	 	 p	=	0.222	 p	=	0.276	
0	to	2	Years	Before	
Implementation	of	Telemedicine	
	 -0.0252**	 	  -0.032	
	 (0.012)	 	  (0.0233)	
	  p	=	0.039	 	  p	=	0.173	
	      
Observations	 650	 650	 		 650	 650	
*	=	significant	at	the	10%	level,	**=	significant	at	the	5%	
level	 	   
Note:	standard	errors	shown	in	parentheses,	county	and	year	fixed	effects	and	control	
variables	(Table	1)	included	in	all	regressions	
	
results	for	YPLL	are	in	the	upper	panel,	and	those	for	PPHD	are	in	the	lower	panel.	The	first	two	
columns	contain	estimates	from	Ordinary	Least	Squares	(OLS)	regressions	with	the	outcome	
variable	weighted	by	county	population	and	the	last	two	columns	contain	estimates	from	the	
unweighted	versions	of	the	dependent	variable.	While	none	of	these	coefficient	estimates	are	
statistically	significant,	the	estimates	for	HadTelemed𝑖t	are	negative	in	both	the	YPLL	and	PPHD	
population-weighted	regressions.	This	is	consistent	with	telemedicine	lowering	YPLL	and	PPHD,	
i.e.,	the	presence	of	telemedicine	improving	general	health.	However,	in	addition	to	not	being	
statistically	significant,	these	estimates	were	not	robust	to	the	inclusion	of	lead2𝑖t,	a	two-year	
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leading	indicator	that	accounts	for	prior	trends.	A	statistically	significant	coefficient	for	the	
leading	indicator	leadp𝑖t	is	found	in	the	weighted	regression	for	PPHD,	indicating	that	there	may	
have	been	a	preexisting	trend	in	this	outcome.	So,	though	it	is	promising	that	the	initial	
estimates	show	decreases	in	YPLL	and	PPHD,	the	fact	that	these	coefficient	estimates	are	
statistically	insignificant	and	not	robust	to	inclusion	of	a	leading	indicator	precludes	drawing	any	
conclusions	about	the	impact	of	simply	having	a	telemedicine	program	on	length	and	quality	of	
life.	
Table	3	presents	regressions	designed	to	see	if	specific	service	lines	have	a	clearer	impact	on	
length	and	quality	of	life.	Outcomes	YPLL	and	PPHD	are	regressed	on	treatment	variables	related	
to	whether	or	not	a	county	had	a	tele-primary	care	program	(panel	A)	or	a	tele-cardiology	
program	(panel	B).	Specifically,	HadTelemed𝑖t	=	1	is	limited	to	the	presence	of	the	respective	
service-specific	tele-med	program.	While	some	of	the	coefficient	estimates	again	have	the	
expected	sign	(decreases	in	YPLL	and	PPHD	indicated	by	negative	coefficient	estimates),	they	
too	are	statistically	insignificant	and	not	robust	to	the	inclusion	of	a	leading	indicator	lead2𝑖t.	In	
fact,	the	coefficient	estimates	for	the	PPHD	regressions	conducted	on	the	impact	of	tele-primary	
care	and	tele-cardiology	on	PPHD	both	changed	from	positive	to	negative	with	the	inclusion	of	
the	leading	indicator	(panel	B).	
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Table	3:	Impact	of	Selected	Service	Lines	on	Length	and	Quality	of	Life	 	
		
OLS	-	Weighted	by	
County	Pop.	 		 OLS	-	Unweighted	
	 M1	 M2	 	 M1	 M2	
Panel	A:	Length	of	Life	 Log(YPLL)	 		 Log(YPLL)	
Had	Tele-Primary	Care	with	
Nurse	Practitioner	
-0.0026	 -0.0007	 	 0.0203	 0.0402	
(0.0142)	 (0.0195)	 	 (0.0222)	 (0.0293)	
p	=	0.855	 p	=	0.971	 	 p	=	0.362	 p	=	0.174	
0	to	2	Years	Before	
Implementation	of	
Telemedicine	
	 0.0029	 	  0.0302	
	 (0.0158)	 	  (0.0293)	
	 p	=	0.857	 	  p	=	0.252	
Observations	 565	 565	 	 565	 565	
Had	Tele-Cardiology	Program	 0.0243	 0.0326	 	 0.0138	 0.0176	
	 (0.0185)	 (0.0279)	 	 (0.0276)	 (0.0404)	
	 p	=	0.193	 p	=	0.246	 	 p	=	0.620	 p	=	0.665	
0	to	2	Years	Before	
Implementation	of	
Telemedicine	
	 0.0087	 	  0.0041	
	 (0.0208)	 	  (0.0303)	
	 p	=	0.678	 	  p	=	0.893	
	      
Observations	 565	 565	 	 565	 565	
Panel	B:	Quality	of	Life	 Log(PPHD)	 		 Log(PPHD)	
Had	Tele-Primary	Care	with	
Nurse	Practitioner	
0.0092	 -0.0084	 	 0.0393	 0.0174	
(0.0224)	 (0.0344)	 	 (0.0445)	 (0.0545)	
p	=	0.684	 p	=	0.808	 	 p	=	0.380	 p	=	0.750	
0	to	2	Years	Before	
Implementation	of	
Telemedicine	
	 -0.0266	 	  -0.0333	
	 (0.0263)	 	  (0.0299)	
	 p	=	0.315	 	  p	=	0.269	
Observations	 565	 565	 	 565	 565	
Had	Tele-Cardiology	Program	 0.0183	 -0.0156	 	 0.0125	 -0.02923	
	 (0.0221)	 (0.0353)	 	 (0.0261)	 (0.045)	
	 p	=	0.3497	 p	=	0.659	 	 p	=	0.632	 p	=	0.518	
0	to	2	Years	Before	
Implementation	of	
Telemedicine	
	 -0.0353	 	  -0.045	
	 (0.0254)	 	  (0.0338)	
	 p	=	0.168	 	  p	=	0.187	
	      
Observations	 565	 565	 		 565	 565	
*	=	significant	at	the	10%	level,	**=	significant	at	the	5%	level	 	
Note:	standard	errors	shown	in	parentheses,	county	and	year	fixed	effects	and	control	
variables	(Table	1)	included	in	all	regressions	
	
	 30	
Figures	1-4	show	the	estimated	𝛽4	and	𝛽5	coefficients	from	equations	(4)	and	(5)	
regressed	on	the	outcomes	YPLL	and	PPHD.		The	vertical	line	at	zero	represents	the	
implementation	year.		The	estimated	𝛽4	values	for	YrPrep𝑖t	(p	=	0	to	6)	from	equation	(4)	are	
plotted	to	the	left	of	the	vertical	line,	and	estimated	𝛽5	values	for	YrPostp𝑖t	(p	=	0	to	3)	from	
equation	(5)	are	plotted	to	the	right	of	it.		These	estimated	values	show	the	differences	in	trends	
for	YPLL	and	PPHD	between	treatment	and	control	counties	prior	to	and	after	implementation	
of	tele-primary	care	and	tele-cardiology.	These	figures	show	a	probable	violation	of	the	common	
trend	assumption	because	the	leading	indicator	estimates	are	not	consistently	close	to	zero.	In	
Figure	1,	for	example,	the	difference	in	trends	for	YPLL	before	the	implementation	(i.e.,	𝛽4	
coefficient	estimates)	of	tele-primary	care	deviate	from	zero,	especially	for	p	=	4,	5,	and	6		
(–4,	–5,	and	–6	on	the	figure),	indicating	that	the	identifying	assumption	may	not	hold	in	this	
case.	Also,	there	is	not	a	notable	divergence	away	from	zero	after	implementation	(i.e.,	𝛽5	
coefficient	estimates),	meaning	that	the	implementation	of	tele-primary	care	did	not	have	a	
significant	effect	on	YPLL	in	treatment	counties.	Similar	conclusions	can	be	draw	from	graphs	2-4	
about	tele-cardiology’s	effect	on	YPLL	and	tele-primary	care	and	tele-cardiology’s	effects	on	
PPHD.	The	dynamic	effects	of	Figures	3	and	4	will	be	discussed	further	in	Section	VII.	
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Figure	1:	Divergence	in	Log	YPLL	Before	and	After	Adoption	of	Tele-Primary	Care	
	
	
	
Figure	2:	Divergence	in	Log	YPLL	Before	and	After	Adoption	of	Tele-Cardio	
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Figure	3:	Divergence	in	Log	PPHD	Before	and	After	Adoption	of	Tele-Primary	Care	
	
	
Figure	4:	Divergence	in	Log	YPLL	Before	and	After	Adoption	of	Tele-Cardio	
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b. Tele-Cardiology	
	
	 Table	4	reports	regression	results	with	CSD	as	the	health	outcome	variable.		This	
regression	is	designed	to	investigate	whether	counties	with	tele-cardiology	service	lines	saw	a	
change	in	the	number	of	circulatory	system-related	deaths.	A	decrease	in	deaths	due	to	
circulatory	problems	is	expected	to	decline	with	the	increased	access	to	cardiology	specialists	
that	tele-cardiology	provides.	As	in	previous	tables,	the	first	two	columns	of	Table	4	contain	
estimates	from	Ordinary	Least	Squares	(OLS)	regressions	weighted	by	county	population	and	the	
last	two	columns	contain	estimates	from	the	unweighted	versions	of	the	same	OLS	regressions.	
These	estimates,	too,	are	negative	(which	indicates	a	positive	effect	of	tele-cardiology)	but	not	
quite	statistically	significant	or	robust	to	the	inclusion	of	a	leading	indicator.	The	graphical	
representation	of	prior	trends	in	Figure	5	does	nearly	hold	to	the	expectation	that	estimates	
prior	to	year	zero	are	close	to	zero.	However,	the	estimates	after	implementation	do	not	show	a	
steady	decline,	but	rather	increase,	then	decrease	dramatically	and	rise	again.	So,	while	it	does	
seem	encouraging	that	estimates	of	the	effect	of	tele-cardiology	implementation	are	headed	in	
the	expected	direction	with	a	decrease	in	cardiac-related	deaths,	solid	inferences	cannot	be	
drawn	from	the	model.	
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Table	4:	Impact	of	Tele-Adult	Cardiology	on	Cardiac-Related	Deaths	
		
OLS	-	Weighted	by	
County	Pop.	 		 OLS	-	Unweighted	
	 M1	 M2	 	 M1	 M2	
Panel	A:	Cardiac-Related	Deaths	 Log(CSD)	 		 Log(CSD)	
Had	Tele-Cardiology	Program	 -0.3081	 0.0243	 	 -0.1879	 0.0145	
	 (0.2414)	 (0.2982)	 	 (0.1442)	 (0.1981)	
	 p	=	0.206	 p	=	0.935	 	 p	=	0.196	 p	=	0.942	
0	to	2	Years	Before	
Implementation	of	Telemedicine	
	 0.3392**	 	  0.2139*	
	 (0.1404)	 	  (0.1161)	
	  p	=	0.018	 	  p	=	0.069	
	      
Observations	 486	 486	 	 486	 486	
*	=	significant	at	the	10%	level,	**=	significant	at	the	5%	level	 	
Note:	standard	errors	shown	in	parentheses,	county	and	year	fixed	effects	and	control	
variables	(Table	1)	included	in	all	regressions	
	
	
Figure	5:	Divergence	in	Log	CSD	Before	and	After	Adoption	of	Tele-Cardio	
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c. Tele-Primary	Care	
	
	The	same	regression	framework	was	used	to	elicit	the	effects	of	implementing	a	tele-
primary	care	service	line.	Increased	access	to	primary	care	providers	should,	in	theory,	reduce	
the	number	of	preventable	hospitalizations	by	providing	essential	care	before	a	medical	issue	
necessitates	hospital-level	treatment.	It	should	also	increase	screenings	for	and	consistent	
monitoring	of	chronic	conditions	like	diabetes.	Therefore,	the	model	was	used	to	estimate	the	
effects	of	implementing	a	tele-primary	care	service	line	on	preventable	hospitalization	rates	
(PHR)	and	on	the	percentage	of	diabetics	enrolled	in	Medicare	who	are	receiving	blood	sugar	
monitoring	(PctDM).	Here	again,	the	first	two	columns	in	Table	5	contain	estimates	from	
Ordinary	Least	Squares	(OLS)	regressions	weighted	by	county	population	and	the	last	two	
columns	contain	estimates	from	the	unweighted	versions	of	the	same	OLS	regressions.		Neither	
of	these	estimates	are	significant	and,	in	fact,	both	have	the	sign	opposite	that	which	was	
predicted.	The	leading	estimates	are	also	not	close	to	zero	prior	to	implementation	as	expected	
and	vary	rather	than	showing	a	steady	trend	post-implementation	(Figures	6	and	7).	So,	no	
useful	inferences	can	be	drawn	from	these	estimates	either.	
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Table	5:	Impact	of	Tele-Primary	Care	with	Nurse	Practitioner	 	   
		
OLS	-	Weighted	by	
County	Pop.	 		 OLS	-	Unweighted	
	 M1	 M2	 	 M1	 M2	
Panel	A:	Preventable	
Hospitalizations	 Log(PHR)	 		 Log(PHR)	
Had	Tele-Primary	Care	with	
Nurse	Practitioner	
0.0224	 0.02417	 	 0.0131	 -0.0091	
(0.2086)	 (0.0393)	 	 (0.0286)	 (0.0416)	
	 p	=	0.286	 p	=	0.541	 	 p	=	0.649	 p	=	0.828	
0	to	2	Years	Before	
Implementation	of	Telemedicine	
	 0.0027	 	  -0.0337	
	 (0.0377)	 	  (0.0347)	
	  p	=	0.943	 	  p	=0.334	
	      
Observations	 565	 565	 	 565	 565	
Panel	B:	Diabetes	 Log(PctDM)		 		 Log(PctDM)	
Had	Tele-Primary	Care	with	
Nurse	Practitioner	
-0.0034	 0.005	 	 -0.0142	 -0.011	
(0.007)	 (0.0139)	 	 (0.0086)	 (0.0162)	
	 p	=	0.630	 p	=	0.719	 	 p	=	0.104	 p	=	0.497	
0	to	2	Years	Before	
Implementation	of	Telemedicine	
	 0.0128	 	  0.0048	
	 (0.0131)	 	  (0.0163)	
	  p	=	0.334	 	  p	=	0.768	
	      
Observations	 565	 565	 		 565	 565	
*	=	significant	at	the	10%	level	 	   
Note:	standard	errors	shown	in	parentheses,	county	and	year	fixed	effects	and	control	
variables	(Table	1)	included	in	all	regressions	
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Figure	6:	Divergence	in	Log	PHR	Before	and	After	Adoption	of	Tele-Primary	Care	
	
Figure	7:	Divergence	in	Log	PctDM	Before	and	After	Adoption	of	Tele-Primary	Care	
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VII. Discussion	
	
Though	this	study	did	not	find	any	statistically	significant	results,	many	of	the	estimates	
at	least	had	the	predicted	signs	which	is	encouraging	given	that	telemedicine	has	only	recently	
come	to	be	commonly	used	in	medical	practice.	Some	of	these	estimates	were	large	with	large	
standard	errors,	too,	indicating	that	telemedicine	may	have	a	great	impact,	though	this	model	is	
not	able	to	accurately	estimate	that	impact.	
	Because	of	the	newness	of	telemedicine’s	widespread	use,	data	on	the	number	of	
patients	using	each	service	line,	longitudinal	patient	outcomes,	cost	of	provision	of	care,	etc.,	
are	not	readily	available	for	study.	As	a	result,	it	is	possible	that	the	number	of	individuals	
treated	by	telemedicine	was	not	large	enough	for	a	county-level	effect	to	be	detected	by	this	
study.	Ideally,	a	study	would	compare	telemedicine	users	to	others	before	and	after	the	
implementation	of	telemedicine.	However,	individual	de-identified	data	was	not	available	for	
analysis.	Future	studies	may	be	able	to	elicit	true	causal	outcomes	if	the	data	mentioned	above	
do	become	available.	
Additionally,	measurable	changes	in	health	outcomes	at	the	county	level	may	not	be	
realized	immediately	after	implementation	of	a	telemedicine	program.	At	the	time	of	this	study,	
only	3	years	of	post-implementation	data	are	available.	That	may	be	insufficient	for	statistical	
analysis	if	there	is	a	time	lag	between	implementation	of	a	telemedicine	program	and	changes	in	
health	outcomes.	Future	studies	with	more	post-implementation	data	might	be	better	suited	to	
accurately	evaluate	the	county-level	change	affected	by	these	programs.	A	longer	post-
implementation	observation	period	may	also	be	useful	in	analyzing	the	extended	dynamic	
effects	of	the	programs.	In	Figures	3	and	4,	for	example,	the	estimates	change	sharply	from	
negative	to	positive	in	the	second	or	third	year	post-implementation,	respectively,	meaning	the	
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programs	increased	reported	PPHD	(the	opposite	of	the	intended	effect).	This	may	be	due	to	an	
increased	awareness	of	one’s	own	health	with	the	implementation	of	tele-primary	care	
programs	since	the	PPHD	measure	is	self-reported.	Further	analysis	of	later	observation	periods	
might	be	able	to	examine	if	the	increase	in	PPHD	persists.		
Lastly,	there	was	evidence	of	probable	violation	of	the	common	trend	assumption	that	
underlies	the	difference-in-differences	methodology.	Future	studies	should	address	this	issue	by	
better	identifying	the	control	(i.e.,	non-treatment)	groups	so	as	to	obtain	greater	similarity	
between	the	control	and	treatment	group	trends	prior	to	implementation.		
UMMC	is	aware	of	the	potential	for	growth	in	the	area	of	data	collection	and	analysis	
and	intends	to	use	some	of	the	resources	provided	by	the	grant	that	accompanied	their	being	
named	a	National	Telehealth	Center	of	Excellence	towards	that	end.	Director	of	the	Center	for	
Telehealth	Michael	Adcock	says,	“While	our	center	has	been	able	to	show	some	impressive	
outcomes,	we	have	not	had	the	staff	to	focus	on	researching	telehealth	delivery	models	and	
outcome	comparisons.	That	is	vital	work	that	needs	to	be	done,	and	we	are	well	positioned	to	
do	it.	This	funding	and	designation	will	allow	us	to	build	on	our	comprehensive	program	and	
develop	the	research	to	support	further	changes	in	models	of	delivery”	(UMMC,	2017).	
The	hope	here	is	that	telemedicine	does	continue	to	grow	in	the	state	of	Mississippi	and	
that	collection	and	analysis	of	related	data	will	add	to	the	body	of	knowledge	on	the	subject.	
Results	of	prior	studies	on	patient	outcomes	from	specific	programs	like	UMMC’s	Diabetes	
Telehealth	Network	have	shown	promising	results	in	both	outcomes	and	cost	reduction	(UMMC,	
2017).	Perhaps	as	the	adoption	of	telemedicine	continues	to	spread	and	more	and	better	data	
becomes	available	for	examination,	studies	of	similar	design	may	be	able	to	elicit	causal	links	
between	telemedicine	programs	and	public	health	outcomes	at	the	county	or	even	state	level.	
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